TY - JOUR
T1 - Glucokinase gene is genetic marker for NIDDM in American blacks
AU - Chiu, K. C.
AU - Province, M. A.
AU - Permutt, M. A.
PY - 1992/7
Y1 - 1992/7
N2 - Glucokinase (ATP:D- glucose- 6 - phosphotransferase), expressed exclusively in liver and pancreatic islet β-cells, catalyzes the first step of glycolysis and acts as glucose sensor and metabolic signal generator in these tissues. The enzyme plays a key role in glucose homeostasis and as such is an excellent candidate for inherited defects predisposing to non-insulin-dependent diabetes mellitus (NIDDM). A compound-imperfect dinucleotide (CA)n repeat element was found ∼10-kb 3′ of the human glucokinase gene on chromosome 7p, which revealed polymorphism with alleles differing in size by 2-15 nucleotides in unrelated individuals. A polymerase chain reaction assay was developed, and genomic DNA from 275 biologically unrelated American black individuals was typed for glucokinase alleles. The differences in allelic frequencies between individuals with NIDDM and nondiabetic individuals were compared. After typing 112 diabetic and 163 nondiabetic subjects, we found five different-sized alleles, with Z defined as the most common allele, Z + 2, Z + 4, Z + 10, and Z - 15. The Z allele was more common in nondiabetic subjects than in diabetic patients (60.4 vs. 49.6%, P = 0.012). The Z + 4 allele was more common in diabetic patients than in nondiabetic subjects (20.1 vs. 12.0%, P = 0.009). After adjusting for age, sex, and body mass index, the Z + 4 allele continued to have a positive association with NIDDM (P= 0.0018), and the Zallele had a negative association with NIDDM (P = 0.0334). The Z + 4 allele, transmitted as an autosomal dominant trait, appeared to be the most significant one at this locus. No difference was found in the clinical characteristics between the diabetic patients with or without the Z + 4 allele, after adjusting for multiple comparisons. These results indicate that the dinucleotide (CA)n repeat polymorphism at the glucokinase locus is a genetic marker for NIDDM in American blacks. We estimate that the presence of at least one Z + 4 allele increases the odds of NIDDM in this racial group by 2.85 times for the same age, sex, and body mass index combination.
AB - Glucokinase (ATP:D- glucose- 6 - phosphotransferase), expressed exclusively in liver and pancreatic islet β-cells, catalyzes the first step of glycolysis and acts as glucose sensor and metabolic signal generator in these tissues. The enzyme plays a key role in glucose homeostasis and as such is an excellent candidate for inherited defects predisposing to non-insulin-dependent diabetes mellitus (NIDDM). A compound-imperfect dinucleotide (CA)n repeat element was found ∼10-kb 3′ of the human glucokinase gene on chromosome 7p, which revealed polymorphism with alleles differing in size by 2-15 nucleotides in unrelated individuals. A polymerase chain reaction assay was developed, and genomic DNA from 275 biologically unrelated American black individuals was typed for glucokinase alleles. The differences in allelic frequencies between individuals with NIDDM and nondiabetic individuals were compared. After typing 112 diabetic and 163 nondiabetic subjects, we found five different-sized alleles, with Z defined as the most common allele, Z + 2, Z + 4, Z + 10, and Z - 15. The Z allele was more common in nondiabetic subjects than in diabetic patients (60.4 vs. 49.6%, P = 0.012). The Z + 4 allele was more common in diabetic patients than in nondiabetic subjects (20.1 vs. 12.0%, P = 0.009). After adjusting for age, sex, and body mass index, the Z + 4 allele continued to have a positive association with NIDDM (P= 0.0018), and the Zallele had a negative association with NIDDM (P = 0.0334). The Z + 4 allele, transmitted as an autosomal dominant trait, appeared to be the most significant one at this locus. No difference was found in the clinical characteristics between the diabetic patients with or without the Z + 4 allele, after adjusting for multiple comparisons. These results indicate that the dinucleotide (CA)n repeat polymorphism at the glucokinase locus is a genetic marker for NIDDM in American blacks. We estimate that the presence of at least one Z + 4 allele increases the odds of NIDDM in this racial group by 2.85 times for the same age, sex, and body mass index combination.
UR - http://www.scopus.com/inward/record.url?scp=0026710603&partnerID=8YFLogxK
M3 - Article
C2 - 1612198
AN - SCOPUS:0026710603
SN - 0012-1797
VL - 41
SP - 843
EP - 849
JO - Diabetes
JF - Diabetes
IS - 7
ER -